January 02, 2026

Curative Treatment After First-Line Immunotherapy Improves Survival in HCC

Curative treatment—resection, transplantation, and/or local ablation—following first-line immunotherapy is infrequently received, but when it was utilized, it significantly improved overall survival o...

The ASCO Post

January 02, 2026

Pathology Priorities 2026: The ASCP Vision

ASCP President Gregory Davis reveals his key concerns for the year ahead – and the link between pathology and pottery

The Pathologist

January 02, 2026

Multiply Your Possibilities: The Proveo 8x 3D Digital Ophthalmic Microscope

The new Leica digital “ecosystem” delivers real-time 3D 4K visualization, seamless data integration, optimized ergonomics, and flexible viewing options

The Ophthalmologist

January 01, 2026

ROP Genetic Variants

Surfactant protein gene variants linked to ROP risk: a new genetic window into retinal vascular disease

The Ophthalmologist

December 29, 2025

Addressing the Regulatory Documentation Bottleneck to Transform Drug Approvals

Agentic AI combined with human control points creates a new paradigm for accelerating documentation while maintaining regulatory integrity.

The Medicine Maker

December 24, 2025

Quiz Time!

What do you know about amyloidosis?

The Pathologist

December 24, 2025

The Lens Divide: Generational Attitudes to Vision Correction

New report reveals how Gen Z, Millennials, and Gen X view contact lenses

The Ophthalmologist

December 23, 2025

ABA Gains—But Can Medicaid Afford It?

Surging Medicaid costs and fraud concerns drive state cuts to applied behavior analysis, alarming families and providers alike.

KFF Health News

December 23, 2025

The Risks After Cosmetic Surgery

Court records describe missed red flags, delayed escalation, and preventable harm following elective cosmetic surgery.

KFF Health News